Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Lelongt

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Nephrologie|December 4, 1998
[Molecular basis of renal development]B Lelongt, B Legallicier, P Ronco
Kidney International|August 1, 1988
Nephritogenicity of proteoglycans. II. A model of immune complex nephritisH Makino, B Lelongt, Y S Kanwar
Kidney International|August 1, 1988
Nephritogenicity of proteoglycans. III. Mechanism of immune deposit formationH Makino, B Lelongt, Y S Kanwar
Kidney International|October 1, 1987
Maturation of the developing renal glomerulus with respect to basement membrane proteoglycansB Lelongt, H Makino, Y S Kanwar
Kidney International|June 1, 1987
Status of glomerular proteoglycans in aminonucleoside nephrosisB Lelongt, H Makino, Y S Kanwar
The Journal of Cell Biology|March 24, 1997
Matrix metalloproteinases MMP2 and MMP9 are produced in early stages of kidney morphogenesis but only MMP9 is required for renal organogenesis in vitroB Lelongt, G Trugnan, G Murphy, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1988
Decreased de novo synthesis of proteoglycans in drug-induced renal cystic diseaseB Lelongt, F A Carone, Y S Kanwar
The Journal of Biological Chemistry|January 9, 1999
Matrix metalloproteinase 2 (MMP2) and MMP9 are produced by kidney collecting duct principal cells but are differentially regulated by SV40 large-T, arginine vasopressin, and epidermal growth factorR Piedagnel, G Murphy, P M Ronco, et al.
Current Opinion in Nephrology and Hypertension|February 24, 2001
Do matrix metalloproteinases MMP-2 and MMP-9 (gelatinases) play a role in renal development, physiology and glomerular diseases?B Lelongt, B Legallicier, R Piedagnel, et al.
The American Journal of Pathology|September 1, 1992
Influence of genetics on the nephritogenic potential of proteoglycansB Lelongt, N Kashihara, H Makino, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Nephrologie|December 4, 1998
[Molecular basis of renal development]B Lelongt, B Legallicier, P Ronco
Kidney International|August 1, 1988
Nephritogenicity of proteoglycans. II. A model of immune complex nephritisH Makino, B Lelongt, Y S Kanwar
Kidney International|August 1, 1988
Nephritogenicity of proteoglycans. III. Mechanism of immune deposit formationH Makino, B Lelongt, Y S Kanwar
Kidney International|October 1, 1987
Maturation of the developing renal glomerulus with respect to basement membrane proteoglycansB Lelongt, H Makino, Y S Kanwar
Kidney International|June 1, 1987
Status of glomerular proteoglycans in aminonucleoside nephrosisB Lelongt, H Makino, Y S Kanwar
The Journal of Cell Biology|March 24, 1997
Matrix metalloproteinases MMP2 and MMP9 are produced in early stages of kidney morphogenesis but only MMP9 is required for renal organogenesis in vitroB Lelongt, G Trugnan, G Murphy, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1988
Decreased de novo synthesis of proteoglycans in drug-induced renal cystic diseaseB Lelongt, F A Carone, Y S Kanwar
The Journal of Biological Chemistry|January 9, 1999
Matrix metalloproteinase 2 (MMP2) and MMP9 are produced by kidney collecting duct principal cells but are differentially regulated by SV40 large-T, arginine vasopressin, and epidermal growth factorR Piedagnel, G Murphy, P M Ronco, et al.
Current Opinion in Nephrology and Hypertension|February 24, 2001
Do matrix metalloproteinases MMP-2 and MMP-9 (gelatinases) play a role in renal development, physiology and glomerular diseases?B Lelongt, B Legallicier, R Piedagnel, et al.
The American Journal of Pathology|September 1, 1992
Influence of genetics on the nephritogenic potential of proteoglycansB Lelongt, N Kashihara, H Makino, et al.
Pageof 3